-
Categories
-
Pharmaceutical Intermediates
-
Active Pharmaceutical Ingredients
-
Food Additives
- Industrial Coatings
- Agrochemicals
- Dyes and Pigments
- Surfactant
- Flavors and Fragrances
- Chemical Reagents
- Catalyst and Auxiliary
- Natural Products
- Inorganic Chemistry
-
Organic Chemistry
-
Biochemical Engineering
- Analytical Chemistry
- Cosmetic Ingredient
-
Pharmaceutical Intermediates
Promotion
ECHEMI Mall
Wholesale
Weekly Price
Exhibition
News
-
Trade Service
Gastroparesis is a chronic gastrointestinal disease that seriously affects gastric motility.
Gastroparesis is a chronic gastrointestinal disease that seriously affects gastric motility.
This study is a single-center randomized controlled study.
Of the patients in this study, 22 were idiopathic gastroparesis patients, and 14 were diabetic gastroparesis patients.
diabetes
Figure: The effect of 5-HT 4 receptor agonist on the recovery of intestinal motility in patients with gastroparesis
This study confirmed that intravenous injection of Felcisetrag (Felcisetrag) can significantly accelerate the gastric, small intestine and colon transport capacity of patients with gastroparesis, and the effect is safe.
This study confirmed that intravenous injection of Felcisetrag (Felcisetrag) can significantly accelerate the gastric, small intestine and colon transport capacity of patients with gastroparesis, and the effect is safe.
Original source:
Victor Chedid.
wiley.
Leave a message here